Industry profile: global sales growth moderating, but still strong growth
Article Abstract:
The forecast for the trend reflecting the growth of pharmaceuticals in terms of sales, is expected to slow down between 2005 and 2010 due factors such as, pricing, a rising proportion of inexpensive generics, etc. The market share of various nations in this sector, globally, is discussed. United States has emerged as the leader, taking up a share of 45%.
Publication Name: Standard & Poor's Industry Surveys: Health Care
Subject: Health care industry
ISSN: 0196-4666
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Global sales growth moderating but still strong
Article Abstract:
The sales of pharmaceutical industry in United States and other parts of the globe grew 6.2 percent in 2006, which is slightly lower than 7 percent growth in 2005. The growth is expected to continue in future.
Publication Name: Standard & Poor's Industry Surveys: Health Care
Subject: Health care industry
ISSN: 0196-4666
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Industry profile - global sales growth likely to keep moderate pace
Article Abstract:
The 2006 performance of major pharmaceutical companies in terms of revenue and growth and its forecast for 2007 are discussed.
Publication Name: Standard & Poor's Industry Surveys: Health Care
Subject: Health care industry
ISSN: 0196-4666
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Global sales approach the half-trillion mark. Industry profile: global drug sales moderating. Worldwide sales exceed $430 billion
- Abstracts: Key industry ratio and statistics. How the industry operates. Key industry ratios and statistics
- Abstracts: Industry trends. Generics take center state
- Abstracts: Current environment: bad debt still taking its toll. How to analyze a healthcare facility company. Bad debt: finally on the mend?
- Abstracts: Industry trends. part 2